148 related articles for article (PubMed ID: 38540371)
21. Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?
Yoshida H; Naka T; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Virchows Arch; 2021 Aug; 479(2):407-412. PubMed ID: 33404855
[TBL] [Abstract][Full Text] [Related]
22. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases.
Ding H; Wu YL; Wang YX; Zhu FF
Asian Pac J Cancer Prev; 2014; 15(4):1675-9. PubMed ID: 24641388
[TBL] [Abstract][Full Text] [Related]
25. Discovery and validation of novel biomarkers for detection of cervical cancer.
Li Z; Chen J; Zhao S; Li Y; Zhou J; Liang J; Tang H
Cancer Med; 2021 Mar; 10(6):2063-2074. PubMed ID: 33624385
[TBL] [Abstract][Full Text] [Related]
26. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
27. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.
Kim HJ; Do IG; Jeon HK; Cho YJ; Park YA; Choi JJ; Sung CO; Lee YY; Choi CH; Kim TJ; Kim BG; Lee JW; Bae DS
Hum Pathol; 2013 Jan; 44(1):62-8. PubMed ID: 22939954
[TBL] [Abstract][Full Text] [Related]
28. Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues.
Shen Y; Li Y; Ye F; Wang F; Wan X; Lu W; Xie X
Exp Mol Med; 2011 Jun; 43(6):358-66. PubMed ID: 21519184
[TBL] [Abstract][Full Text] [Related]
29. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
30. Identification of autophagy-associated miRNA signature for the cervical squamous cell cancer and high-grade cervical intraepithelial lesions.
Bayramoglu Tepe N; Bozgeyik E; Bozdag Z; Balat O; Ozcan HC; Ugur MG
Reprod Biol; 2021 Sep; 21(3):100536. PubMed ID: 34298410
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.
Park H; Lee MJ; Jeong JY; Choi MC; Jung SG; Joo WD; Lee C; An HJ
Gynecol Oncol; 2014 Dec; 135(3):565-72. PubMed ID: 25230213
[TBL] [Abstract][Full Text] [Related]
32. p53 expression in carcinoma of the cervix.
Hunt CR; Hale RJ; Buckley CH; Hunt J
J Clin Pathol; 1996 Dec; 49(12):971-4. PubMed ID: 9038732
[TBL] [Abstract][Full Text] [Related]
33. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma.
Bozgeyik E; Tepe NB; Bozdag Z
Pathol Res Pract; 2020 Nov; 216(11):153159. PubMed ID: 32841775
[TBL] [Abstract][Full Text] [Related]
34. New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology.
Seo MJ; Bae SM; Kim YW; Kim YW; Hur SY; Ro DY; Lee JM; Namkoong SE; Kim CK; Ahn WS
Gynecol Oncol; 2005 Mar; 96(3):621-9. PubMed ID: 15721403
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8
Rotman J; Heeren AM; Gassama AA; Lougheed SM; Pocorni N; Stam AGM; Bleeker MCG; Zijlmans HJMAA; Mom CH; Kenter GG; Jordanova ES; de Gruijl TD
Clin Cancer Res; 2020 Jul; 26(14):3791-3802. PubMed ID: 32220890
[TBL] [Abstract][Full Text] [Related]
36. Prognosis and treatment of primary adenocarcinoma and adenosquamous cell carcinoma of the uterine cervix.
Pekin T; Kavak Z; Yildizhan B; Kaya H
Eur J Gynaecol Oncol; 2001; 22(2):160-3. PubMed ID: 11446486
[TBL] [Abstract][Full Text] [Related]
37. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.
Gius D; Funk MC; Chuang EY; Feng S; Huettner PC; Nguyen L; Bradbury CM; Mishra M; Gao S; Buttin BM; Cohn DE; Powell MA; Horowitz NS; Whitcomb BP; Rader JS
Cancer Res; 2007 Aug; 67(15):7113-23. PubMed ID: 17671178
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia and cervical squamous carcinoma tissues].
Zhao Q; Wu YM; He Y; Wang XL; Chen S; Qian XH; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):914-20. PubMed ID: 24506961
[TBL] [Abstract][Full Text] [Related]
39. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.
Muralidhar B; Winder D; Murray M; Palmer R; Barbosa-Morais N; Saini H; Roberts I; Pett M; Coleman N
J Pathol; 2011 Aug; 224(4):496-507. PubMed ID: 21590768
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues.
Ono A; Kumai T; Koizumi H; Nishikawa H; Kobayashi S; Tadokoro M
Hum Pathol; 2009 Jan; 40(1):41-9. PubMed ID: 18755499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
